Wat we doen

Amsterdam UMC Ventures Holding BV is opgericht in 1995 om de Amsterdam Universitair Medische Centra in staat te stellen via participaties maatschappelijke en economische meerwaarde te creëren uit onderwijs en onderzoek, zónder dat publiek en privaat geld wordt vermengd. Doelstelling is om middels de spin off route bij te dragen aan een product voor de patiënt op basis van Amsterdam UMC onderzoek en het genereren van waarde door dividend of exit welke dan terugvloeit naar het Amsterdam UMC.

Amsterdam UMC Ventures Holding BV stimuleert en faciliteert ondernemerschap, investeert in new ventures en beheert aandelenbelangen. We verzorgen voor verschillende ondernemingen governance, finance & control, management en advies. Dit doen we ook voor ondernemingen van UvA Ventures Holding BV en HvA Ventures Holding BV, de holdings van de Universiteit van Amsterdam (UvA) en de Hogeschool van Amsterdam (HvA).

De gemeenschappelijke portfolio van Amsterdam UMC Ventures Holding BV, UvA Ventures Holding BV en HvA Ventures Holding BV is onderverdeeld in 3 categorieën: New Ventures, Contractonderzoek en Services. Alle ondernemingen van Amsterdam UMC Ventures Holding BV horen bij de categorie New Ventures.

Nieuws

11 november 2024

Phlox Therapeutics Secures New Funding to Advance RNA Therapies for Genetic Cardiomyopathies

Naarden, The Netherlands, 6 November 2024 – Phlox Therapeutics, a private biotechnology company focused on developing innovative RNA-based therapies for cardiomyopathies, has successfully raised new funding to accelerate its lead program on genetic laminopathies. This round of funding adds ROM Utrecht Region to the existing syndicate of FIRST fund (managed by BGV), Amsterdam UMC Venture Holding, and Utrecht Health Seed Fund (UHSF). In addition, non-dilutive funding through Dutch Research Council (NWO) and a public-private partnership with the Hubrecht Institute – supported by Health~Holland -further bolsters Phlox’s financial resources.  

Lees verder

27 juni 2024

Kepler Vision Technologies in het nieuws!

Aan de baanbrekende technologie van Kepler Vision Technologies is veel aandacht besteed in de media de afgelopen dagen. Daar zijn wij natuurlijk trots op. Bekijk hier het televisiefragment:

https://nos.nl/nieuwsuur/video/2526132-deze-ai-camera-herkent-een-val-oplossing-voor-personeelstekort-in-de-zorg 

Lees verder

Bekijk meer nieuws

Een aantal veelgestelde vragen

1. Why Amsterdam UMC Ventures Holding BV?

Amsterdam UMC Ventures Holding BV, established in 1995, is a 100% subsidiary of the Amsterdam University Medical Centers (Amsterdam UMC). It facilitates top researchers from the Amsterdam UMC in their attempts to set up companies based on their scientific findings in the area of medical Research & Development or production arising from this. At the same time, with its activities, Amsterdam UMC Ventures Holding B.V. implements the Amsterdam UMC’s valorisation policy, which is promoting the use of scientific knowledge for the benefit of patients, for the development of e.g. a new medicine, medical device or diagnostic method.

2. Why start a startup company at the Amsterdam UMC?

Valorisation is the fourth mission of the Amsterdam UMC. This concerns activities that add value to the scientific knowledge beyond the academic domain. For researchers, seeing a product based on their invention enter the market and benefit patients is very rewarding. One of the routes from research results to a product is via development in a startup company. This route is taken when established companies are not interested enough yet to license the technology (due to it still being at an early stage), the Amsterdam UMC (IXA) believes in the potential of the technology, the technology is within the core interests of the Amsterdam UMC, and the researchers are enthusiastic about setting up a startup company.
To support the growth of startups that utilize university IP or know how and to separate public funding and private revenue streams, Amsterdam UMC took the initiative to set up Amsterdam UMC Ventures Holding BV.

3. What can Amsterdam UMC Ventures Holding do for you?

Scientists / Doctors
Amsterdam UMC Ventures teams up with the inventor(s) when it comes to commercialising the findings and provides feedback on the business model, together with the Technology Transfer Office of the Amsterdam UMC, IXA. On founding a startup, Amsterdam UMC Ventures establishes the legal, financial and governance structures of the company, for example drafting the shareholders agreement, statutes and setting up the financial administration. The extent of support depends on the extent of participation of Amsterdam UMC Ventures in the startup, which can vary over time. Amsterdam UMC Ventures also has an active role in finding new team members, esp. those with business development, financial modelling and marketing skill sets.

Entrepreneurs
Amsterdam UMC Ventures is always on lookout for entrepreneurs for its portfolio companies. Please contact Ross Gordon for more information. Are you interested in technologies or research domains at the Amsterdam UMC? Please contact IXA.

Investors
Are you interested in Amsterdam UMC Ventures’ portfolio companies? Please contact Ross Gordon.

Students
Students interested in working at a startup can contact the UvA Ventures portfolio company StudiJob

4. What are the portfolio companies of Amsterdam UMC Ventures Holding?

The Amterdam UMC Ventures portfolio companies are as diverse as the disciplines at the Amsterdam UMC. An overview of all Amsterdam UMC Ventures can be found in the combined portfolio of Amsterdam UMC Ventures Holding, UvA Ventures Holding and HvA Ventures Holding. They form part of the ‘New Ventures’ category.

5. How does founding an Amsterdam UMC startup work?

The beginning
A scientist with an invention should first contact IXA Office Amsterdam UMC. IXA is Amsterdam UMC’s department responsible for commercialising scientific knowledge. IXA (through its business developers and patent attorney) a.o. advises on the most suitable valorisation route, takes care of patent filing, negotiates licensing and research collaboration contracts with external and startup companies, and provides proof-of-concept funding in collaboration with Amsterdam UMC Ventures.

From founding onwards
After the startup is founded, Amsterdam UMC Ventures guides the startup through establishing a legal, financial and governance structure as already eluded on in section 3. In addition Amsterdam UMC Ventures also supports funding, launching customer, prototyping etc.